shire plc (SHP:London)
Transactions by SHIRE PLC (SHP) in the last 6 months
Shire plc (LSE:SHP) acquired assets of SCM Pharma on August 13, 2014. The deal has saved 74 jobs. Andrew Ross and Toby Underwood of PwC were appointed joint administrators to SCM Pharma.
Shire plc (LSE:SHP) acquired BIKAM Pharmaceuticals, Inc. from CHL Medical Partners III, L.P. of CHL Healthcare Partners, Biosciences Fund II of Fidelity Biosciences, HealthCare Ventures LLC and other shareholders for $94.5 million on July 9, 2014. Cash consideration paid on closing was $2.5 million. Further contingent consideration of up to $92 million may be payable by Shire in future periods dependent upon the achievement of certain development, regulatory and sales ...
CHL Healthcare Partners
CHL Medical Partners III, L.P.
HealthCare Ventures LLC
ArmaGen Technologies, Inc. announced that it will receive funding from new investor Shire plc on July 23, 2014. The company will receive upfront payment of $15 million in cash and equity, an additional equity investment in the transaction.
|Allergan Inc/United States||$212.63 USD||+0.45|
|Astellas Pharma Inc||¥1,703 JPY||+47.50|
|CSL Ltd||A$86.36 AUD||+1.08|
|Mylan Inc/PA||$57.51 USD||+0.68|
|Valeant Pharmaceuticals International Inc||C$165.46 CAD||-0.32|
|View Industry Companies|